LAURA GRUNDY: Open Payments
NPI 1346209673 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,943 in 115 payments from 20 companies in 2025. Trend: 2023 $1,654 · 2024 $1,921 · 2025 $1,943
Food & beverage: $1,943
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $246 |
| Otsuka America Pharmaceutical, Inc. | 15 | $240 |
| AstraZeneca Pharmaceuticals LP | 10 | $199 |
| GlaxoSmithKline, LLC. | 14 | $188 |
| Lilly USA, LLC | 12 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $109 |
| PFIZER INC. | 6 | $106 |
| Novo Nordisk Inc | 5 | $96 |
| SANOFI-AVENTIS U.S. LLC | 4 | $93 |
| Abbott Laboratories | 4 | $90 |
Products named: REXULTI, TRELEGY ELLIPTA, AIRSUPRA, OTEZLA, Kerendia, JARDIANCE, TZIELD, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
